Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

FDA takes action to remove biosimilars roadblock

1 September 2015 Business

The US Food and Drug Administration proposes system to name biosimilar drugs

Syngenta fends off Monsanto takeover bid

27 August 2015 Business

Unmoving objection to merger leads US giant to drop pursuit

Job cuts at Lundbeck and DSM

27 August 2015 Business

Each cutting around 1000 roles in reorganisation efforts

Female sexual desire drug approved

26 August 2015 Business

Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions

Indian pharma under increased regulatory scrutiny

21 August 2015 Business

Import bans and tightened rules pose a significant challenge for companies

Porous pills could be largest industrial 3D printing use

20 August 2015 Business

US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure

Greek crisis puts pressure on pharmaceuticals

17 August 2015 Business

Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece

Deadly chemical blast at Chinese port

14 August 2015 Business

Explosion at warehouse in Tianjin kills at least 50 and injures hundreds, while ammonia leak sparks mass evacuations in Nanchong

No one should be denied medication


14 August 2015 Business

Exclusive interview
 with Yusuf Hamied
, chairman of Indian generic drugmaker Cipla

Shire makes hostile bid for Baxalta

10 August 2015 Business

Recently spun-out from Baxter, Baxalta is resisting the deal, saying it wants time to prove its true value

Grabbing slices of the immuno-oncology pie

5 August 2015 Business

Another spate of immuno-oncology dealmaking adds to fervour in pharma’s ‘hottest space’

Berry plastics to buy Avintiv for $2.5bn

4 August 2015 Business

Deal helps Berry diversify from food packaging into speciality medical materials

AstraZeneca sells off drugs to streamline portfolio

3 August 2015 Business

Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus

Lightweight composites drive Solvay to buy Cytec

31 July 2015 Business

$5.5bn deal launches Solvay into aerospace materials business

Biogen to develop gene therapies with AGTC

29 July 2015 Business

$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases

Hikma boosts generics with Roxane buyout

29 July 2015 Business

Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market

Celgene to buy immune-inflammatory specialist Receptos

29 July 2015 Business

$7.2bn deal further strengthens Celgene’s position in immunology

Allergan steps away from generics with sale to Teva

29 July 2015 Business

$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and catapults Teva into global pharma top 10

Three dead in Chinese petrochemical plant fire

27 July 2015 Business

Further four workers injured after leaking oil ignited at Qingyang Petrochemical plant in Gansu province

US regulator says DuPont’s safety programme ‘failed’

24 July 2015 Business

The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme

Chemical firms seek better grasp of biomanufacturing

23 July 2015 Business

The search is on for better alternatives to the ‘broken’ way companies harness compound-making organisms

An unsustainable hypocrisy

21 July 2015 Business

Social responsibility should extend through the whole supply chain, not just be a tool to put pressure on feedstock suppliers

US import ban imposed on Indian pharma firm

16 July 2015 Business

Concerns over manufacturing processes at Emcure facility prompts Food and Drug Administration to block drug shipments

US chemical maker Platform expands with Alent purchase

15 July 2015 Business

Platform Specialty Products plans to enlarge its scope and reach by acquiring British chemicals firm Alent for $2.1bn

Thermo Fisher to buy Alfa Aesar chemical supplies

8 July 2015 Business

Research chemicals business no longer a strategic fit for owner Johnson Matthey